| Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study NM Kuderer, TK Choueiri, DP Shah, Y Shyr, SM Rubinstein, DR Rivera, ... The Lancet 395 (10241), 1907-1918, 2020 | 1847 | 2020 |
| Somatic mutation of CDKN1B in small intestine neuroendocrine tumors JM Francis, A Kiezun, AH Ramos, S Serra, CS Pedamallu, ZR Qian, ... Nature genetics 45 (12), 1483-1486, 2013 | 344 | 2013 |
| The genomic landscape of small intestine neuroendocrine tumors MS Banck, R Kanwar, AA Kulkarni, GK Boora, F Metge, BR Kipp, L Zhang, ... The Journal of clinical investigation 123 (6), 2502-2508, 2013 | 329 | 2013 |
| Association of convalescent plasma therapy with survival in patients with hematologic cancers and COVID-19 MA Thompson, JP Henderson, PK Shah, SM Rubinstein, MJ Joyner, ... JAMA oncology 7 (8), 1167-1175, 2021 | 173 | 2021 |
| Sequencing of C harcot–M arie–T ooth disease genes in a toxic polyneuropathy AS Beutler, AA Kulkarni, R Kanwar, CJ Klein, TM Therneau, R Qin, ... Annals of neurology 76 (5), 727-737, 2014 | 91 | 2014 |
| Exome-level comparison of primary well-differentiated neuroendocrine tumors and their cell lines GK Boora, R Kanwar, AA Kulkarni, J Pleticha, M Ames, G Schroth, ... Cancer genetics 208 (7-8), 374-381, 2015 | 80 | 2015 |
| Association of the Charcot–Marie–Tooth disease gene ARHGEF10 with paclitaxel induced peripheral neuropathy in NCCTG N08CA (Alliance) GK Boora, AA Kulkarni, R Kanwar, P Beyerlein, R Qin, MS Banck, ... Journal of the neurological sciences 357 (1-2), 35-40, 2015 | 54 | 2015 |
| Testing of candidate single nucleotide variants associated with paclitaxel neuropathy in the trial NCCTG N08C1 (Alliance) GK Boora, R Kanwar, AA Kulkarni, A Abyzov, J Sloan, KJ Ruddy, ... Cancer medicine 5 (4), 631-639, 2016 | 52 | 2016 |
| Racial disparities in COVID-19 outcomes among black and white patients with cancer J Fu, SA Reid, B French, C Hennessy, C Hwang, NT Gatson, N Duma, ... JAMA network open 5 (3), e224304-e224304, 2022 | 47 | 2022 |
| Association between androgen deprivation therapy and mortality among patients with prostate cancer and COVID-19 AL Schmidt, MD Tucker, Z Bakouny, C Labaki, CY Hsu, Y Shyr, ... JAMA network open 4 (11), e2134330-e2134330, 2021 | 40 | 2021 |
| Bortezomib-based consolidation or maintenance therapy for multiple myeloma: a meta-analysis S Zhang, AA Kulkarni, B Xu, H Chu, T Kourelis, RS Go, ML Wang, ... Blood cancer journal 10 (3), 33, 2020 | 33 | 2020 |
| Interplay of immunosuppression and immunotherapy among patients with cancer and COVID-19 Z Bakouny, C Labaki, P Grover, J Awosika, S Gulati, CY Hsu, ... JAMA oncology 9 (1), 128-134, 2023 | 32 | 2023 |
| Neurotoxicity to DRG neurons varies between rodent strains treated with cisplatin and bortezomib JL Podratz, A Kulkarni, J Pleticha, R Kanwar, AS Beutler, NP Staff, ... Journal of the neurological sciences 362, 131-135, 2016 | 29 | 2016 |
| The CoVID‐TE risk assessment model for venous thromboembolism in hospitalized patients with cancer and COVID‐19 A Li, NM Kuderer, CY Hsu, Y Shyr, JL Warner, DP Shah, V Kumar, S Shah, ... Journal of thrombosis and haemostasis 19 (10), 2522-2532, 2021 | 28 | 2021 |
| Risk for stroke and myocardial infarction with abiraterone versus enzalutamide in metastatic prostate cancer patients AA Kulkarni, N Rubin, A Tholkes, S Shah, CJ Ryan, PL Lutsey, A Prizment, ... Esmo Open 6 (5), 100261, 2021 | 24 | 2021 |
| Comparative analysis of antibiotic exposure association with clinical outcomes of chemotherapy versus immunotherapy across three tumour types AA Kulkarni, M Ebadi, S Zhang, MA Meybodi, AM Ali, T DeFor, R Shanley, ... ESMO open 5 (5), e000803, 2020 | 22 | 2020 |
| Percutaneous transluminal renal stenting for transplant renal artery stenosis S Sharma, A Potdar, A Kulkarni Catheterization and Cardiovascular Interventions 77 (2), 287-293, 2011 | 22 | 2011 |
| Impact of antibiotics and proton pump inhibitors on clinical outcomes of immune check point blockers in advanced non-small cell lung cancers and metastatic renal cell cancer. A Kulkarni, M Kumar, DF Pease, Y Wang, TE DeFor, M Patel Journal of Clinical Oncology 37 (15_suppl), e20520-e20520, 2019 | 20 | 2019 |
| A systematic framework to rapidly obtain data on patients with cancer and COVID-19: CCC19 governance, protocol, and quality assurance M Abidi, DM Aboulafia, MK Accordino, JD Acoba, MS Ahluwalia, ... Cancer cell 38 (6), 761-766, 2020 | 18 | 2020 |
| Real-world outcomes and clinical predictors of immune checkpoint inhibitor monotherapy in advanced lung cancer S Zhang, DF Pease, AA Kulkarni, M Kumar, RM Shanley, B Xu, SP Joshi, ... Clinical Medicine Insights: Oncology 15, 11795549211004489, 2021 | 17 | 2021 |
Rahul KanwarStatisticianVerified email at mayo.edu
